IL-1β is a potent pro-inflammatory mediator, produced after the most frequent activation of the nucleotide-binding oligomerization domain-like receptor (NLR) containing purine domain-3 proven in chronic obstructive pulmonary disease and IPF. Here, IL1B is linked to idiopathic pulmonary fibrosis.